86 related articles for article (PubMed ID: 18554073)
1. Pharmacotherapy after myocardial infarction: disease management versus usual care.
Chan V; Cooke CE
Am J Manag Care; 2008 Jun; 14(6):352-8. PubMed ID: 18554073
[TBL] [Abstract][Full Text] [Related]
2. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
3. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
4. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
Winkelmayer WC; Charytan DM; Levin R; Avorn J
Am J Kidney Dis; 2006 Feb; 47(2):301-8. PubMed ID: 16431259
[TBL] [Abstract][Full Text] [Related]
5. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
7. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
8. A managed care organization's use of integrated health management to improve secondary prevention of coronary artery disease.
Berthiaume JT; Davis J; Taira DA; Thein KK
Am J Manag Care; 2007 Mar; 13(3):142-7. PubMed ID: 17335357
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
11. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
[TBL] [Abstract][Full Text] [Related]
12. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
13. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):895-900. PubMed ID: 18936454
[TBL] [Abstract][Full Text] [Related]
14. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
15. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial.
Majumdar SR; Tsuyuki RT; McAlister FA
Am Heart J; 2007 Jan; 153(1):22.e1-8. PubMed ID: 17174632
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
[TBL] [Abstract][Full Text] [Related]
17. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
Rasmussen S; Abildstrom SZ; Rasmussen JN; Gislason GH; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Madsen M
Med Care; 2008 Jan; 46(1):70-7. PubMed ID: 18162858
[TBL] [Abstract][Full Text] [Related]
18. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization.
Cooke CE; Fatodu H
J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843
[TBL] [Abstract][Full Text] [Related]
19. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
20. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]